Conducted an extensive review of commonly used ingredients and various bioactives impacting cardiovascular health.
Identified a unique blend, including an ingredient typically associated with women’s health but also beneficial for cardiovascular systems.
Supported the blend choice with comprehensive clinical research.
Identified ‘Quatrefolic’ – a specialized folate form, proven to lower homocysteine levels, thereby reducing plaque formation risks and kidney strain.
Combined this with a blend of omega 3, 6, 7, and 9, underpinned by clinical evidence for a holistic cardiovascular health solution.
Successfully launched ‘Multi Omega’, now a top-performing brand in Jubilant PharmaNova’s portfolio, exemplifying strategic innovation and market alignment.
